The expanding waistline and increasing cholesterol levels many women face after menopause may be a factor in the stiffening of their arteries, increasing their risk of cardiovascular disease, researchers report in Hypertension: Journal of the American Heart Association.
People with diabetes are 1.6 times more likely to seek out complementary and alternative medicine than those in the general population. That’s the conclusion of a recent study from the Medical University of South Carolina based on information from a nationally representative sample of the US population.
A measure of blood glucose control all too familiar to people with diabetes apparently fluctuates of its own accord throughout the year, researchers report.
Regular exercise among women with type 2 diabetes may not only reduce waist size, but may also reduce the amount of visceral fat surrounding organs in the abdomen — the type of fat known to be associated with insulin resistance, a study shows.
The Food and Drug Administration (FDA) approved Symlin, an injectable medicine to control blood sugar for adults with type 1 and type 2 diabetes. Symlin is to be used in addition to insulin therapy in patients who cannot achieve adequate control of their blood sugars on intensive insulin therapy alone.
Mom may have been right when she said breakfast is the most important meal of the day. A small study suggests that skipping that morning meal may be a bad move for the heart, and possibly the waistline.
Heart disease affects women of all racial and ethnic groups, as well as women with other illnesses, such as diabetes.
Pre-diabetes – the term, recently coined by health officials, indicates a partly elevated blood sugar level that will likely develop into full diabetes within 10 years if nothing is done to stop it.
Men with type 2 diabetes seem to be less likely to develop prostate cancer, overall, a new study indicates.
The new diabetes vaccine involves injecting a protein which stops the body from destroying insulin-producing cells. Currently those with Type 1 diabetes need daily injections of synthetic insulin because the pancreas stops producing its own.